Serono Rebif Contract With Prime Bases Rebates On Comparative Total Cost Of Care, Patient Adherence
Executive Summary
EMD Serono will pay Prime Therapeutics rebates on use of multiple sclerosis drug Rebif if patients have higher overall costs than those using a different MS drug and if patients maintain a specified level of adherence. Rebif is the third drug in the pharmacy benefit manager’s CareCentered Contract program.